Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Gorovitz Aaron, Director. Officer active across 1 company, notably NRX Pharmaceuticals, Inc.. In total, 3 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €10k. Activity tracked since 30 August 2023. The latest transaction was filed on 30 August 2023 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
3 of 3 declarations
Aaron Gorovitz is a Director at NRX Pharmaceuticals, Inc. As a board member, he participates in the governance of the company and strategic decision-making. His experience in the pharmaceutical sector allows him to make significant contributions to discussions on the company's direction. He is committed to supporting growth and innovation within NRX Pharmaceuticals.